Double-blind, 12 month follow-up, placebo-controlled trial of mifepristone on cognition in alcoholics: the MIFCOG trial protocol

Overview of attention for article published in BMC Psychiatry, February 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)
Good Attention Score compared to outputs of the same age and source (76th percentile)

So far, Altmetric has seen 6 news stories from 1 outlets.

On Thursday, November 1, 2018, Corcept Therapeutics (CORT) reportedits Q3-2018 results and held a conference call.

We were about to publish an update when Judge Wigenton denied Teva’s motion against Corcept.

On Monday, October 1, 2018, Corcept Therapeutics announcedthat relacorilant received an orphan designation from the FDA for…

The valuation for Corcept Therapeutics (CORT) has stabilized for a bit, and it’s a welcome relief from the recent turbulence.

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 2 additional news stories.